Диссертация (1140388), страница 21
Текст из файла (страница 21)
– P.767 -70.154. McConnell, S. Do antimicrobial-impregnated central venous catheters preventcatheter-related bloodstream infection? / S. McConnell, P. Gubbins, E. Anaissie //Clin. Infect. Dis. – 2003. – V. 37. – P. 65-72.155. Mechanism of resistance to the toxicity of cyclophosphamide / M.P. Gamcsik,M.E. Dolan, B.S. Andersson, D. Murray // Curr. Pharm. Design.
– 1999. – V. 5. –P. 587–605.156. Mermel, L. Prevention of intravascular catheter-related infections / L. Mermel //Ann. Intern. Med. – 2000. – V. 132. – P. 391-402.157. Michel, C.C. Microvascular permeability / C.C. Michel, F.E. Curry// Physiological Reviews. – 1999. – 79(3). – P. 703–761.158. Mickley, V.Central venous catheters: many questions, few answers / V.Mickley // Nephrol.
Dial. Transplant. – 2002. – V. 17. – P. 1368-1373.159. Miller, D. Guidelines for the prevention of intravascular catheter-relatedinfections: recommendations relevant to interventional radiology / D. Miller, N.O'Grady // J. Vase. Intervent. Rad. – 2003. – V. 14. – P. 133-136.160. Movat, H.Z.
Tumor necrosis factor and interleukin-1: role in acute inflammationand microvascular injury / H.Z. Movat // J. Lab. Clin. Med. – 1987. – V. 110. – P.668-681.136161. Nakamaru M., Competition by allelopathy proceeds in traveling waves: colicinimmunestrainaidscolicin-sensitive strain/M.Nakamaru , Y.Iwasa// Theor. Popul.
Biol. – 2000. – V. 57. – P. 131-144.162. Neumann, G. Continuous model for the rock-scissors-paper game betweenbacteriocin producing bacteria / G. Neumann, S. Schuster // J. Math. Biol. – 2007.– V. 54. – P. 815–846.163. Neumann, G. Modeling the rock–scissors–paper game between bacteriocinproducing bacteria by Lotka–Volterra equations / G. Neumann , S. Schuster //Discrete Contin. Dyn. Syst. – 2007. – B.
8. - P. 207–228.164. Nishe, M. Antibacterial peptides "bacteriocins": an overview of their diversecharacteristics and applications / M. Nishe, J. Nagao, K. Sonomoto // BiocontrolSci. 2012. – V. 17, № 1. – P. 1-16.165. Novel roles for chemokines and fibroblasts in interstitial fibrosis / C.M.Hogaboam, M.L. Steinhauser, S.W. Chensue, et al. // Kidney Int. – 1998. – V. 54,№6. – P. 2152-2159.166. O’Toole, G. A.
To build a biofilm / G. A. O’Toole // J. Bacteriol. - 2003. – V.185. – P. 2687-2689.167. O’Toole, G. Biofilm formation as microbial development / G. O’Toole, H.B.Kaplan, R. Kolter // Annu. ReV. Microbiol. – 2000. – V. 54. – P. 49–79.168. Outcomes of primary and catheter-related bacteremia / B. Renaud, et al. // Am. J.ResP.
Crit. Care Med. – 2001. – V. 163. – P. 1584–1590.169. Pag, U. Multiple activities in lantibiotics - models for the design of novelantibiotics? / U. Pag, H.G. Sahl // Curr. Pharm. Des. – 2002. – V. 8. – P. 815-833.170. Pascual, A. Pathogenesis of catheter-related infections: lessons for new designs /A. Pascual // Clin. Microbiol. Infect. – 2002. – V. 8. – P. 256–264.171. Pathogenesis of vascular catheter-related infections / R.J.
Sheretz, et al. // eds.Catheter-related infections. New York. Marcel Dekker. – 1997. –P. 1–30.172. Peeters, E. Comparison of multiple methods for quantification of microbialbiofilms grown in microtiter plates / E. Peeters, H.J.Nelis, T. Coenye // J.137Microbiol Methods. – 2008. – V. 72. – P. 157-65.173. Pharmacodynamicsofglycopeptidesinthemouseperitonitismodelof Streptococcus pneumoniae or Staphylococcus aureus infection / J. D. Knudsen,K. Fuursted, S. Raber, F.
Espersen, and N. Frimodt-Moller // Antimicrob. AgentsChemother. – 2000. – V. 44. – P. 1247-1254.174. Preventing complications of central venous catheterization / D. McGee, M.Gould // N. Engl. J. Med. – 2003. – Vol. 348. – P. 1123-1133.175. Prevention of biofilm formation on titanium surfaces modified with conjugatedmolecules comprised of antimicrobial and titanium-binding peptides / M.Yoshinari, et al.
// Biofouling. – 2010. – V. 26. – P. 103-110.176. Production of class II bacteriocins by lactic acid bacteria; an example ofbiological warfare and communication / V. G. Eijsink, L. Axelsson, D.B. Diep,L.S. Havarstein, H. Holo, I.F. Nes // Antonie Van Leeuwenhoek. – 2002. - V. 81,№ 1–4. – P. 639-654.177. Proliferative and Non-proliferative Lesions of the Rat and Mouse Soft Tissue,Skeletal Muscle and mesothelium / P.Greaves, L.
Chouinard, H. Ernst, L.Mecklenburg, I.M. Pruimboom-Brees, M. Rinke, S. Rittinghausen, S. Thibault, J.von Erichsen, T. Yoshida // J. Toxicol. Pathol. – 2013. – V. 26, №3. – P. 1–26.178. Protein antimicrobial barriers to bacterial adhesion / Bower C.K. et al. // J. DairySci.
– 1998. – V. 81. – № 10. – P. 2771–8.179. Proteinases and glomerular matrix turnover / M. Davies, J. Martin, G.J. Thomas,et al. // Kidney Int. – 1992. – 41. – P. 671–7.180. Qi, F. The group I strain of Streptococcus mutans, UA140, produces boththe lantibiotic mutacin I and a nonlantibiotic bacteri- ocin, mutacin IV / F. Qi , P.Chen , P.W. Caufield // Appl. Environ Microbiol. – 2001. – V. 67. – P. 15-21.181.
Quantitative mouse model of implant-associated osteomyelitis and the kinetics ofmicrobial growth, osteolysis, and humoral immunity / D. Li, et al. // J. OrthoP.Res. – 2008. – V. 26. – P. 96-105.182. Regulation of the association of alpha 6 beta 4 with vimentin intermediate138filaments in endothelial cells / S.M. Homan, R. Martinez, A. Benware, et al.// ExP. Cell Res.
– 2002. – V. 281. – P. 107-14.183. Reunanen, J. Lantibiotic nisin and its detection methods / J. Reunanen// Academic dissertation Finland Helsinki. – 2007. – V. 41. – P. 7670-7878.184. Riley M.A. Bacteriocins: ecology and evolution / M.A. Riley, M. ChavanBacteriocins // Springer. – Berlin.
– 2007. – P. 45-92.185. Riley M.A., Wertz J.E. Bacteriocins: evolution, ecology, and application / M.A.Riley, J.E. Wertz // Annu. ReV. Microbiol. – 2002. – V. 56. – P. 117–137.186. Safdar, N. Meta-analysis: methods for diagnosing intravascular device-relatedbloodstream infection / N. Safdar, J. Fine, D. Maki // Ann. Intern. Med. — 2005. –V. 142. – P. 451-466.187. Sahl, H.G. Biosynthesis and biological activities of lantibiotics with unique posttranslational modifications / H.G.
Sahl, R.W. Jack, G.Bierbaum // EuropeanJournal of Biochemistry. – 1995. – V. 230. – P. 827–853.188. Sahl, H.G. Lantibiotic: biosynthesis and biological activities of uniquely modifiedpeptides from gram-positive bacteria / H.G. Sahl , G. Bierbaum // Annu. ReV.Microbiol. – 1998. – V. 52. – P. 41–79.189. Saint, S. Enhancing the safety of critically patients by reducing urinary andcentral venous catheter-related infections / S. Saint, R.
Savel, M. Matthay // Am.J. ResP. Crit. Care Med. – 2002. – V. 165. – P. 1475-1479.190. Salamon, G.D. The local effects of Cachectin/Tumor Necrosis Factor on WoundHeoling / G.D. Salamon, A. Kasid, D.T. Cromack // Ann. Surg. – 1991. – V. 214,№2. – P. 175-180.191. Sandiford, S. Identification, characterization, and recombinant expression ofepidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcusepidermidis that displays potent activity against Staphylococci./ S. Sandiford, M.Upton. // Antimicrob. Agents Chemother. – 2012.
– V. 56. – № 3. – P. 1539-47.192. Sang, Y. Antimicrobial peptides and bacteriocins: alternatives to traditionalantibiotics / Y. Sang, F. Blecha. // Anim. Health Res. ReV. – 2008. – V. 9. – № 2.139– P. 227–35.193. Scott, M.G. Cationic antimicrobial peptides and their multifunctional role in theimmune system / M.G. Scott, R.E.
Hancock // Crit. ReV. Immunol. – 2000. – V.20. – P. 407-431.194. Senok, A.C. Probiotics: facts and myths / A.C. Senok, A.Y. Ismaeel, G.A. Botta// Clin. Microbiol. Infect. – 2005. – V.11. - P. 958-966.195. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipidbilayer membranes by alpha-helical antimicrobial and cell non-selectivemembrane-lytic peptides / Y. Shai. // Biochim. Biophys. Acta. – 1999. – V. 1462. –№1-2. – P. 55–70.196. Shand, R.F. Archaeal antimicrobials: an undiscovered country. In Archaea: newmodels for prokaryotic biology / R.F. Shand, K.J.
Leyva, edited by P. Blum //Norfolk: Caister Academic. – 2008. – P. 233-242.197. Staphylococcus epidermidis surfactant peptides promote biofilm maturation anddissemination of biofilm-associated infection in mice / Rong Wang, Khan A.Burhan, Cheung Y.C. Gordon, Bach L. Thanh-Huy, Max Jameson-Lee, Kok-FaiKong, Queck Y. Shu, and Michael Otto // J Clin Invest. – 2011. – 121(1). – P.
238248.198. Stenfors Arnesen, L.P. From soil to gut: Bacillus cereus and its food poisoningtoxins/L.PArnesenStenfors,A. Fagerlund, P.E.Granum// FEMS Microbiol. ReV. – 2008. – V. 32. – P. 579–606.199. Structural characterization of lacticin 3147, a two-peptide lantibiotic withsynergistic activity / N.I. Martin, T. Sprules, M.R. Carpenter, P.D. Cotter, C.Hill , R.P. Ross, J.C.
Vederas // Biochemistry (Mosc). – 2004. – V. 43. – P. 3049–3056.200. Structure-activity relationships in the peptide antibiotic nisin: Role ofdehydroalanine5/W.C.Chan,H.M.Dood,N.Horn,etal.//Appl.Environ.Microbiol. – 1996. – V. 62., №8. - P. 2966–2969.201. Synergy and duality in peptide antibiotic mechanisms / D.G. McCafferty, P.140Cudic, M.K. Yu, D.C. Behenna, R. Kruger // Curr.
Opin. Chem. Biol. – 1999. – V.3. – P. 672-680.202. Testa, M.M. Antagonistic interactions among evotella intermedia with orallactobacilli / M.M. Testa, R. Ruiz de Valladares, I.L. Benito de Cardenas // ResMicrobiol. – 2003. – V. 154. – P. 669-675.203. The “classical” macrophage marker CD68 is strongly expressed in primaryhuman fibroblasts / L.A. Kunz-Schughart, A. Weber, M. Rehli, et al. // Verh.Dtsch.
Ges. Pathol. – 2003. – V. 87. – P. 215-223.204. The Antimicrobial Peptide Database (APD) [Электронный ресурс] – Режимдоступа: http://aps.unmc.edu/AP/main.php.205. The application of biofilm science to the study and control of chronic bacterialinfections / J.W. Costerton, R. Veeh, M. Shirtliff, et. al. // Clin. Invest. – 2003. –V. 112. – P. 1466 – 1477. 77206.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
